Faraday Pharmaceuticals
Ben Haber has over 20 years of experience in the pharmaceutical industry. Ben began their career in 1997 as an Associate Research Data Coordinator at Abbott Laboratories. In 1999, they moved to Immunex as a Senior Clinical Data Analyst and Project Coordinator. In 2002, they joined Berlex Laboratories as a Manager of Clinical Data Management. In 2004, they joined ZymoGenetics as a Manager and Associate Director of Clinical Data Management. In 2011, they joined Dendreon as an Associate Director of Data Management and a Manager of Clinical Programming. In 2014, they moved to Juno Therapeutics, Inc. as an Associate Director and Director of Data Management Programming. In 2017, they joined Nohla Therapeutics as a Director of Data Management. Currently, they are a Senior Director of Data Management at Faraday Pharmaceuticals, Inc.
Ben Haber attended the University of Oregon from 1992 to 1993, where they studied Mathmatics and Pre-med. Ben then attended Northwestern University from 1994 to 1996, where they earned a Bachelor of Science in Biomedical Engineering.
Faraday Pharmaceuticals
Faraday Pharmaceuticals' mission is to improve the quality of life for patients after acute critical illness by minimizing damage to cardiac and skeletal muscle.